David Rossini

1.2k total citations
20 papers, 902 citations indexed

About

David Rossini is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Rossini has authored 20 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Rossini's work include Treatment of Major Depression (15 papers), Bipolar Disorder and Treatment (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). David Rossini is often cited by papers focused on Treatment of Major Depression (15 papers), Bipolar Disorder and Treatment (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). David Rossini collaborates with scholars based in Italy and Japan. David Rossini's co-authors include Raffaella Zanardi, Enrico Smeraldi, Alessandro Serretti, Cristina Cusin, Cristina Lorenzi, A. Lucca, Lorenzo Magri, Enrico Lattuada, Danilo Dotoli and L. Franchini and has published in prestigious journals such as Biological Psychiatry, Psychopharmacology and Psychiatry Research.

In The Last Decade

David Rossini

19 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Rossini Italy	16	380	355	319	191	190	20	902
Christo Minov Germany	12	190 0.5×	155 0.4×	302 0.9×	48 0.3×	254 1.3×	19	768
Carl Björkholm Sweden	12	124 0.3×	331 0.9×	446 1.4×	120 0.6×	193 1.0×	14	1.1k
Monique L. Smith United States	16	320 0.8×	133 0.4×	495 1.6×	81 0.4×	364 1.9×	28	1.3k
Kenneth L. Davis United States	13	516 1.4×	319 0.9×	304 1.0×	124 0.6×	268 1.4×	14	1.2k
Shinn‐Won Lim South Korea	11	254 0.7×	269 0.8×	301 0.9×	22 0.1×	216 1.1×	27	817
Anja Cerovecki Germany	12	358 0.9×	160 0.5×	135 0.4×	119 0.6×	122 0.6×	15	1.1k
D. Attar-Lèvy France	12	574 1.5×	314 0.9×	441 1.4×	102 0.5×	149 0.8×	14	1.4k
M. Patricia Ball United States	16	572 1.5×	246 0.7×	304 1.0×	46 0.2×	466 2.5×	17	1.2k
Baruch Shapira Israel	24	603 1.6×	489 1.4×	364 1.1×	97 0.5×	160 0.8×	40	1.2k
Nicolaas Paul L.G. Verhoeff Canada	16	219 0.6×	185 0.5×	295 0.9×	73 0.4×	131 0.7×	36	788

Countries citing papers authored by David Rossini

Since Specialization

Citations

This map shows the geographic impact of David Rossini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rossini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rossini more than expected).

Fields of papers citing papers by David Rossini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rossini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rossini. The network helps show where David Rossini may publish in the future.

Co-authorship network of co-authors of David Rossini

This figure shows the co-authorship network connecting the top 25 collaborators of David Rossini. A scholar is included among the top collaborators of David Rossini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rossini. David Rossini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zanardi, Raffaella, et al.. (2013). Paroxetine drops versus paroxetine tablets: evaluation of compliance in a six-month study. Rivista di psichiatria. 48(3). 261–7. 4 indexed citations

Rossini, David, A. Lucca, Lorenzo Magri, et al.. (2011). Role of COMT, 5-HT1A, and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation. Depression and Anxiety. 28(7). 568–573. 40 indexed citations

Kato, Masaki, Raffaella Zanardi, David Rossini, et al.. (2009). 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. Psychiatry Research. 167(1-2). 97–105. 24 indexed citations

Mandelli, Laura, Alessandro Serretti, Raffaella Zanardi, et al.. (2007). Antidepressant response in the elderly. Psychiatry Research. 152(1). 37–44. 20 indexed citations

Zanardi, Raffaella, Lorenzo Magri, David Rossini, et al.. (2007). Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. European Neuropsychopharmacology. 17(10). 651–657. 37 indexed citations

Rossini, David, Alessandro Serretti, L. Franchini, et al.. (2007). Reply to Comments by Dr Rico-Villademoros. Journal of Clinical Psychopharmacology. 27(1). 99–99.

Mandelli, Laura, Alessandro Serretti, Cristina Colombo, et al.. (2006). Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: An exploratory analysis. Psychiatry and Clinical Neurosciences. 60(5). 598–604. 33 indexed citations

Rossini, David, Lorenzo Magri, A. Lucca, et al.. (2005). Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial. The Journal of Clinical Psychiatry. 66(12). 1569–1575. 73 indexed citations

Rossini, David, A. Lucca, Raffaella Zanardi, Lorenzo Magri, & Enrico Smeraldi. (2005). Transcranial magnetic stimulation in treatment-resistant depressed patients: A double-blind, placebo-controlled trial. Psychiatry Research. 137(1-2). 1–10. 84 indexed citations

10.

Rossini, David, Alessandro Serretti, L. Franchini, et al.. (2005). Sertraline Versus Fluvoxamine in the Treatment of Elderly Patients With Major Depression. Journal of Clinical Psychopharmacology. 25(5). 471–475. 34 indexed citations

11.

Serretti, Alessandro, Paola Artioli, Raffaella Zanardi, et al.. (2004). Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. Psychopharmacology. 174(4). 504–11. 39 indexed citations

12.

Serretti, Alessandro, Cristina Cusin, David Rossini, et al.. (2004). Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 129B(1). 36–40. 58 indexed citations

13.

Zanardi, Raffaella, Cristina Cusin, David Rossini, Diana De Ronchi, & Alessandro Serretti. (2003). Comparison of Response to Fluvoxamine in Nondemented Elderly Compared to Younger Patients Affected by Major Depression. Journal of Clinical Psychopharmacology. 23(6). 535–539. 23 indexed citations

14.

Serretti, Alessandro, Paola Artioli, Raffaella Zanardi, & David Rossini. (2003). Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(5). 751–757. 29 indexed citations

15.

Cusin, Cristina, Alessandro Serretti, Raffaella Zanardi, et al.. (2002). Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. The International Journal of Neuropsychopharmacology. 5(1). 27–35. 82 indexed citations

16.

Serretti, Alessandro, Raffaella Zanardi, Cristina Cusin, et al.. (2001). Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. European Neuropsychopharmacology. 11(5). 375–380. 92 indexed citations

17.

Zanardi, Raffaella, Alessandro Serretti, David Rossini, et al.. (2001). Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression. Biological Psychiatry. 50(5). 323–330. 176 indexed citations

18.

Serretti, Alessandro, Raffaella Zanardi, Cristina Cusin, et al.. (2001). No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors. Psychiatry Research. 104(3). 195–203. 38 indexed citations

19.

Zanardi, Raffaella, David Rossini, & Alessandro Serretti. (2001). "Dr. Zanardi and Colleagues Reply". The Journal of Clinical Psychiatry. 62(4). 296–296. 1 indexed citations

20.

Franchini, L., et al.. (2000). Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?. Psychiatry Research. 96(1). 81–85. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact